BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11598308)

  • 1. Is there a typical pattern of brain SPECT imaging in Alzheimer's disease?
    Steinling M; Defebvre L; Duhamel A; Lecouffe P; Lavenu I; Pasquier F; Charpentier P
    Dement Geriatr Cogn Disord; 2001; 12(6):371-8. PubMed ID: 11598308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covariance 99mTc-exametazime SPECT patterns in Alzheimer's disease and dementia with Lewy bodies: utility in differential diagnosis.
    Colloby SJ; Taylor JP; Firbank MJ; McKeith IG; Williams ED; O'Brien JT
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):54-62. PubMed ID: 20029055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases.
    Waragai M; Yamada T; Matsuda H
    J Neurol Sci; 2007 Sep; 260(1-2):57-64. PubMed ID: 17493637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
    Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
    J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data.
    Charpentier P; Lavenu I; Defebvre L; Duhamel A; Lecouffe P; Pasquier F; Steinling M
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):661-3. PubMed ID: 11032624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.
    Waragai M; Mizumura S; Yamada T; Matsuda H
    Dement Geriatr Cogn Disord; 2008; 26(6):547-55. PubMed ID: 19066428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
    Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP
    J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease.
    Ceravolo R; Volterrani D; Gambaccini G; Rossi C; Logi C; Manca G; Berti C; Mariani G; Murri L; Bonuccelli U
    Neurol Sci; 2003 Oct; 24(3):162-3. PubMed ID: 14598067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer's disease.
    Nagao M; Sugawara Y; Ikeda M; Fukuhara R; Hokoishi K; Murase K; Mochizuki T; Miki H; Kikuchi T
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):162-8. PubMed ID: 15129697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease.
    McNeill R; Sare GM; Manoharan M; Testa HJ; Mann DM; Neary D; Snowden JS; Varma AR
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):350-5. PubMed ID: 17158559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.
    Pasquier J; Michel BF; Brenot-Rossi I; Hassan-Sebbag N; Sauvan R; Gastaut JL
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1342-8. PubMed ID: 12271417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?
    Talbot PR; Lloyd JJ; Snowden JS; Neary D; Testa HJ
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):306-13. PubMed ID: 9527139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of cerebral blood flow in dementia.
    Kuikka JT
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):516. PubMed ID: 15750828
    [No Abstract]   [Full Text] [Related]  

  • 18. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
    J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99Tcm-HMPAO SPECT in suspected dementia.
    Launes J; Sulkava R; Erkinjuntti T; Nikkinen P; Lindroth L; Liewendahl K; Iivanainen M
    Nucl Med Commun; 1991 Sep; 12(9):757-65. PubMed ID: 1945187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
    Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.